BPH-Related Voiding Dysfunction —i-Tind

We present the most current literature on this therapy. There are ongoing trials evaluating the use of the newer second-generation i-Tind, although there are currently no functional differences from the first-generation device. The pilot study of the first-generation device was shown to improve both IPSS score andQmax over the course of 12  months with a trend to benefit in the 24 to 36-month period. The i-Tind represents another attempt to introduce an office-based procedure for the treatment of BPH. The preliminary results seem to indicate that this device shows efficacy in improving urinary symptoms.SummaryThere is promising evidence for the use of i-Tind as an office-based treatment for BPH. An important consideration, however, will center on patient selection. There will be a cohort of men who elect to undergo this minimally invasive procedure over the gold standard TURP. However, this will not be a viable treatment option for men with particularly large prostate volumes.
Source: Current Bladder Dysfunction Reports - Category: Urology & Nephrology Source Type: research